Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1085 USD | -14.58% | -15.89% | +180.36% |
May. 09 | Kraig Biocraft Laboratories, Inc. Spring Spider Silk Production Trials Exceed Expectations | CI |
Apr. 29 | Kraig Biocraft Laboratories, Inc. Reports Signing Agreements in South East Asia | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 39.99M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -3M | EV / Sales 2022 | - |
Net cash position 2022 | 2.19M | Net cash position 2023 | 803K | EV / Sales 2023 | - |
P/E ratio 2022 |
-7.86
x | P/E ratio 2023 |
-13.2
x | Employees | 41 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.79% |
1 day | -14.58% | ||
1 week | -15.89% | ||
Current month | +21.91% | ||
1 month | +18.19% | ||
3 months | +15.43% | ||
6 months | +261.67% | ||
Current year | +180.36% |
Managers | Title | Age | Since |
---|---|---|---|
Kim Thompson
CEO | Chief Executive Officer | 62 | 06-04-24 |
Jonathan Rice
COO | Chief Operating Officer | 44 | 15-01-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kim Thompson
CEO | Chief Executive Officer | 62 | 06-04-24 |
Jonathan Rice
COO | Chief Operating Officer | 44 | 15-01-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.1085 | -14.58% | 4,053,698 |
24-05-23 | 0.127 | -1.61% | 543,086 |
24-05-22 | 0.1291 | +0.27% | 394,417 |
24-05-21 | 0.1288 | -0.19% | 345,009 |
Delayed Quote OTC Markets, May 24, 2024 at 03:57 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+180.36% | 113M | |
+2.85% | 50B | |
+21.79% | 42.94B | |
+27.82% | 27.25B | |
+9.77% | 19.34B | |
-1.61% | 16.7B | |
+8.04% | 16.1B | |
-11.69% | 15B | |
-25.35% | 15.65B | |
-17.88% | 14.12B |
- Stock Market
- Equities
- KBLB Stock